Speaker 1: Now here's a highlight from Coast to Coast AM on
Speaker 1: iHeart Radio. You are listening to Coast to Coast AM.
Speaker 1: Connie willis here second half. Hopefully some of you or
Speaker 1: all of you are on track with the time. By
Speaker 1: the way, I know some of y'all are feeling it,
Speaker 1: like what's going on? Daylight saving time always does that
Speaker 1: to everybody, right, and yes it should be consistent across
Speaker 1: the board, and any of those of you that follow
Speaker 1: my career, you know that we attempted to do that
Speaker 1: from w w k A out of Orlando. W DBO
Speaker 1: is the AM which you would hear Coast to Coast on.
Speaker 1: We worked it into I think it ended up turning
Speaker 1: into a bill the you know, we were trying to
Speaker 1: get it year round for the you know everybody, and
Speaker 1: we I guess the people that could really make some
Speaker 1: moves said they should do it. You know, they were
Speaker 1: going to start out kind of regionally. They thought was
Speaker 1: that was the better way. I don't know, you know
Speaker 1: what to me? Take the big jump, well, baby steps,
Speaker 1: you know what, people grow up anyway. I'm sorry, that's
Speaker 1: just me. That's just me. Take the take the flying
Speaker 1: elite man, become the Jack Lolanes and the Elane Lolanes
Speaker 1: of the world. But the first person to ever sign
Speaker 1: it was Sonny Bono. That's a that's always kind of
Speaker 1: a neat little story to tell. But anyway, I hope
Speaker 1: you guys are back in action. Your body's starting to
Speaker 1: get used to it. Just you know, hey, come on,
Speaker 1: get over it. Let's go. You lost an hour. Take
Speaker 1: a nap somewhere. Um right, less see spring forward, fallback?
Speaker 1: Right okay, yeah, free spring for Okay, thanks, So come on,
Speaker 1: we should all be good, we should be insane anyway. Um,
Speaker 1: I'm excited for our next guest, and I'm also a
Speaker 1: little like whoa, So hang in there with me on this.
Speaker 1: First of all, if you wanted to know about Elane's books,
Speaker 1: you can, of course go to our website. You can
Speaker 1: of course go to her website, and you can always
Speaker 1: go to my website too at Connie Willis dot com.
Speaker 1: I'll have her information up there too, as well as
Speaker 1: past people's information, and we'll be putting all those people
Speaker 1: on a podcast as well, so you'll always be able
Speaker 1: to get more. So follow that so that you can go.
Speaker 1: I want more of Elaine and I want to be
Speaker 1: able to talk to her because so I'll set up
Speaker 1: some of those live podcasts so that you can do that,
Speaker 1: all right. So I'm just learning the developing of it
Speaker 1: and all the technical parts of it. So anything you'd
Speaker 1: like to do with me and join the shows and
Speaker 1: just enjoy it because we have a good time. Please
Speaker 1: go to Connie Willis dot com and thank you. Now.
Speaker 1: A lot of times when we take callers, there's some
Speaker 1: callers that you know that I guess me as a
Speaker 1: broadcaster I listened to I'm like, hey man, this this
Speaker 1: person is pretty cool, and you guys know that live
Speaker 1: on the air, I'll say, all right, leave your information
Speaker 1: with Donna or call screener, leave information right, and then
Speaker 1: she'll get it back to me. And that's when I'm like, hmmm,
Speaker 1: I think you should be you should have your own
Speaker 1: show with me sometimes. So this is one of the
Speaker 1: guys that's on next that I did that with, and
Speaker 1: you know, lo and behold, he's been on with you know,
Speaker 1: our Bell, He's been on with yours Nori, you know
Speaker 1: a ton of bazillion times. He's been all over the place,
Speaker 1: and it's great to know that he's listening to the
Speaker 1: show and loves to listen to the show and and
Speaker 1: we'll call in. It's just that's always a neat thing
Speaker 1: that it's mutual. That mutual. Now, one of the things
Speaker 1: I like is he's highly intelligent. He knows what he's
Speaker 1: talking about, or at least he leads me to believe it.
Speaker 1: He's really good at that. But I can say, well,
Speaker 1: what's that you know, and he'll he'll do He's kind's
Speaker 1: he understands it might go over your head, so he's
Speaker 1: not going to laugh at you. He'll explain it to you.
Speaker 1: And that is very important because there's a lot of people,
Speaker 1: and you guys have heard him before where they will
Speaker 1: just talk right over your head and you have no
Speaker 1: clue what they just said, and you're like five paragraphs
Speaker 1: back and they're so far ahead of you you know
Speaker 1: you've already lost it. So as he talks, if there's
Speaker 1: anything where I need to stop him, and it's just
Speaker 1: because of me, maybe you're past that, but there's a
Speaker 1: lot more people, probably like me, that are going to
Speaker 1: go what and they are very thankful that I might
Speaker 1: stop him and ask. That way we can stay in
Speaker 1: line with them. So we'll do our best to follow him.
Speaker 1: But he also knows, Hey, you got to dummy it
Speaker 1: down for at least me for sure. And so this
Speaker 1: is Charles Ostman. You've heard him on here before. No
Speaker 1: doubt he's experienced, his experience and clues. I'm going to
Speaker 1: give you a little bit here, and then I'll let
Speaker 1: him do a lot of it too, because I'm sure
Speaker 1: he will. He can name some things that I'll never
Speaker 1: have mentioned. But his experience includes forty five plus years
Speaker 1: in the fields of electronics, material science, computing, artificial intelligence,
Speaker 1: starting with eight years at Lawrence Berkeley Laboratory at the
Speaker 1: University of California, Berkeley, Cool and at Los Alamos National Laboratory.
Speaker 1: Cool Cool, Cool, Cool Cool. He's been a senior fellow
Speaker 1: at the Institute for Global Futures, a consulting grew that
Speaker 1: provides strategic research services to private and government clientele. I
Speaker 1: love this. Co founder of nanosig and organization with the
Speaker 1: primary charter of facilitating investment in nanotechnology related ventures. And
Speaker 1: in fact, basically tonight we're going to be talking about
Speaker 1: nanotechnology as a core catalyst of accelerating next stage evolution.
Speaker 1: What is it and what is it not yet? Now
Speaker 1: wait a minute, Now you might go oh this sounds
Speaker 1: so boring, man, you know, sorry, Connie going to sleep.
Speaker 1: No no, no, no no, no, no, no no, no, no, We're
Speaker 1: gonna not at all. In fact, I love saying nano
Speaker 1: nano earlier, by the way, I thought that was kind
Speaker 1: of cool. But really the biggest thing is and we're
Speaker 1: gonna bring on Charles right now. Welcome once again, Charles.
Speaker 1: And the question what we're gonna ask first is why
Speaker 1: is nanotechnology relevant to us? That is probably the bigger question.
Speaker 1: So Charles, yeay, you're here, Thanks so much. Well in
Speaker 1: Hi Kanye, I've always listened to for a long time,
Speaker 1: and here we are. This is amazing. I'm actually quite astonished,
Speaker 1: I know, and we've made it. I'm very happy about it.
Speaker 1: And what's cool is you have put together some graphics
Speaker 1: so that people can follow on the website. Yeah, that's
Speaker 1: the basic idea. And I wanted to make the point
Speaker 1: that it's not now technology as a singular sort of
Speaker 1: vertical storm of pipe topic development or technology. It's really
Speaker 1: at the center, almost like an actual of a wheel
Speaker 1: with all these different spokes kind of rating out of it.
Speaker 1: And it's a core fundamental technology which actually allows many
Speaker 1: other technologies to be more plausible or possible, I should say,
Speaker 1: in the near future, even the present term. So if
Speaker 1: I had to describe what nanotech actually is, the symbolist
Speaker 1: sort of Akin's razor approach would be this the manipulation
Speaker 1: of matter at the molecular or even atomic scale of pursuit.
Speaker 1: So to me, it was always it's just really really
Speaker 1: itty bitty, itty bitty tiny. Yeah, but is not that
Speaker 1: relevant unless you can do something with it. It's very
Speaker 1: predictable or specific to a cause. She said, I'm sorry,
Speaker 1: I should not say that's funny. I best go. And
Speaker 1: by the way, I've really impressed with your previous guest.
Speaker 1: I mean yes, I mean I should never lived to
Speaker 1: ninety seven and'll be that functional. I don't know. I
Speaker 1: feel robot half the time, so I don't know. She
Speaker 1: is amazing and she's like that all the time. She's
Speaker 1: such a hoot. And you know, I was concerned of
Speaker 1: you know, you're gonna be on lay? Is that cool?
Speaker 1: And she said, you know, when Jack was alive, I
Speaker 1: would get up early because he was the early bird.
Speaker 1: But now that he's not here with us anymore, I
Speaker 1: am back to my old self of being a night owl.
Speaker 1: So she said, I'm good. I'm good to go. So
Speaker 1: that was great, and thanks for being on standby just
Speaker 1: in case. Absolutely. Well, you know, it's interesting my best
Speaker 1: hours at like three to four o'clock in the morning.
Speaker 1: I don't know why, it just turns out that way
Speaker 1: and time. I really do wish that this day light
Speaker 1: losing time. Alcohol it right, I'll get resolved. I almost
Speaker 1: got thrown off because I didn't know exactly what time
Speaker 1: it was and I was doing all my stuff here
Speaker 1: and I've realized, I wait a second, I'm an hour off.
Speaker 1: Now I want to make sure I didn't like miss
Speaker 1: the show or something. So anyway, here we are. We
Speaker 1: thank you for being responsible for that too. So so yeah,
Speaker 1: so okay, nanotechnology were again? Why why why should I
Speaker 1: care about it? What's the big deal with it with me?
Speaker 1: Because whether or not you're looking at computing, medicine, any
Speaker 1: form of telecommunications, any kind of manufacturing, just about all
Speaker 1: the stuff that you've seen or daily life, and you,
Speaker 1: yourself as a person, as a living thing, aren't going
Speaker 1: to be or already are in some ways affected by nanotechnology.
Speaker 1: You may not see it, I mean as hard as
Speaker 1: you now skills anyway, but I mean the artifacts or
Speaker 1: the consequences of nanotechnology is already present in a lot
Speaker 1: of different materials and audito existing products. It may not
Speaker 1: be like you wake up one morning somebody discovered nanotech everywhere.
Speaker 1: It's more of a transition. But we're in that transition now, well,
Speaker 1: I mean aren't we, because like these phones get smaller
Speaker 1: or actually whether well sometimes you want them a little bigger,
Speaker 1: but I like them smaller. But more and more and
Speaker 1: more and more and more and more and more things
Speaker 1: fit in them, and function comes from it. It's not
Speaker 1: a nactor of science, unle a matter of complexity. In fact,
Speaker 1: there's something called more in law, which talks about technologies
Speaker 1: doubles every you know, so many months and so on. Well,
Speaker 1: that's kind of an outdated way of looking at it.
Speaker 1: They be used to measure by the number of transistors
Speaker 1: you could fit into a specific area. But I'll sort
Speaker 1: of go against that, and I would say it's more
Speaker 1: to do with the amount of complexity you can sit
Speaker 1: into a a certain amount of time space. That's probably
Speaker 1: a better way of looking at it, especially now if
Speaker 1: you look at quantum computing, which is on such a
Speaker 1: radical different scale of computational resource that is trying to
Speaker 1: measure the size that transistors completely irrelevant acshally in that context.
Speaker 1: But even before we get to quantum computing, just to
Speaker 1: get to other types of computing, of which there is
Speaker 1: both biological and sort of inorganic mediums you can work with. Again,
Speaker 1: it's not how small is a thing, but rather how
Speaker 1: much functionality can you pack into a specific region of
Speaker 1: space time. So looking at some of the bullet points
Speaker 1: you and I put together, or you put together for me,
Speaker 1: so that I can go through this, because this is
Speaker 1: a whole another world for me. This is out of
Speaker 1: your brain. So what about these smart materials and all
Speaker 1: the self organizing and self assembling all that kind of thing. Sure,
Speaker 1: so I'll start by saying this, we're surrounded by self organizing,
Speaker 1: a self assembling downtech everywhere. Almost living things are just that.
Speaker 1: If you look into a cell, if you look into
Speaker 1: the nucleus of a cell, the organelles, the ribosomes, other protosomes, etc.
Speaker 1: That's what they do. They literally take a part and
Speaker 1: reassemble various molecules to accommodate the physiological requirements of that
Speaker 1: particular cell. And more importantly, how that's organs. There were
Speaker 1: functions with an a larger body. Now it's kind of
Speaker 1: fascinating is in the current scheme of things in terms
Speaker 1: of biolot what I might call nanobiology, one of the
Speaker 1: main target goals right now is to use what I'll
Speaker 1: call quasi viral components to target offending cells by cancer
Speaker 1: cells and be able to nutilize them, or to target
Speaker 1: other try of cells and affect their physiology in some
Speaker 1: kind of hopefully proactive way. Viruses are really good at this,
Speaker 1: and you may be scared flay a minute free or
Speaker 1: people panic, there's actually a good side of this because
Speaker 1: if you sort of break apart a virus, what really
Speaker 1: does It has a proteomic sennature kind of like a
Speaker 1: hand to above all cells are just most of it's
Speaker 1: to say, have an outer sheath of proteins that stick
Speaker 1: out like fingers almost. It's the RNA sennature of that
Speaker 1: particular type of cell, and viruses will target whatever cell
Speaker 1: that third external RNA features won't cling to. That's why
Speaker 1: it has different viruses for specific organisms, even for specific organs.
Speaker 1: That kind of thing. So in a virus encounters the
Speaker 1: right kind of cell, that's supposed to mate for it
Speaker 1: will then for enxonic action, kind of nibulous way to
Speaker 1: the cell ball goes to the cytoplasm. And then and
Speaker 1: then they'll target one of the riber zones are one
Speaker 1: of the other proteosomes and force that protozome to make
Speaker 1: more virus as opposed to making more of the molecular
Speaker 1: structure stuff normally going to keeping that cell functioning. Now,
Speaker 1: that second part we don't like, but the first part
Speaker 1: is wonderful because that excuse me. Now we have a
Speaker 1: way of targeting whatever kind of cell we're looking for,
Speaker 1: cancer cells and doing something with it, hopefully killing it
Speaker 1: or turning it into a type of cell. They'll then
Speaker 1: go after other cancer cells that sort of thing. And
Speaker 1: that's already being done. Oh like a double spy man,
Speaker 1: turn them around, make them go the other way, use them. Well,
Speaker 1: fantastic voyage. Yes, quite bad. It's sort of like that
Speaker 1: in the way. We're not shrinking people now and putting
Speaker 1: them to the submarine, but we are taking already existing
Speaker 1: submarine of sorts of vir entity and using it for
Speaker 1: our purposes. Is that Okay? Now, I've seen videos or
Speaker 1: films or something where they would create like it's almost
Speaker 1: like a let's just say an eighty by eighty bitty
Speaker 1: little like submarine is drone. Yeah, and then you could
Speaker 1: take it and go move it around and then kill
Speaker 1: what you wanted to kill. Is that is that happening?
Speaker 1: That's another we look a different way of looking at
Speaker 1: it would be an artificial immune system. Excuse thing. I'm
Speaker 1: so sorry for my voice. By the way, I've got
Speaker 1: this horrible poll going on, so I promise I won't
Speaker 1: die or anything, but if I sell, by the way,
Speaker 1: before I forget, Um, I really want to thank Ryan
Speaker 1: a lot. He didn't. He did an amazing job getting
Speaker 1: all my stuff posted up there at the eleventh arm
Speaker 1: forty nine minute. Um, he was freely patient let me
Speaker 1: repost all my stuff and he was great. So for
Speaker 1: anybody been checking it out, you want to thank ryanc.
Speaker 1: He did a marvelous job. Just you want to make
Speaker 1: that point. Yeah, go to Coast to Coast am dot
Speaker 1: com and then look for I think it says I'm
Speaker 1: I'm already on the page, so I think it says
Speaker 1: like related feature. So this down below the carousel and
Speaker 1: you'll see the pictures that I'm looking at myself just
Speaker 1: go on, I still don't get it. Yeah, but well
Speaker 1: but that's like, that's why Charles is, you know, gonna
Speaker 1: explain it? Are you called chuck as well? I kept on, Chuck,
Speaker 1: no chart, okay, okay, So anyway, so I'm sorry, seeing
Speaker 1: of biological things in the nano world, this may be
Speaker 1: sort of relevant, and it may be part of how
Speaker 1: we go into discussion later. But there is a quite
Speaker 1: an interest by the FDA to figure out how they're
Speaker 1: going to classify this genre of development from a medical perspector.
Speaker 1: And the reasoning is because in earlier times, there are
Speaker 1: two major categories of regulatory protocols wonder, which covered chemistry,
Speaker 1: that being drugs, the other which covered machines, mostly machines
Speaker 1: that are outside the body. You know, we're revoked up
Speaker 1: to various devices and scanners and that kind of thing,
Speaker 1: and more recently going to implant that sort of thing.
Speaker 1: But all these regulatory protocols were wrapped around machines. Now,
Speaker 1: in the world of nanotex, it's not exactly a chemical,
Speaker 1: but it's not affecting a machine either, not in a
Speaker 1: traditional sense. So what do you kind of write it
Speaker 1: as So in two thousand and six, I was fetched
Speaker 1: upon by the FDA wapp to the Press of Maryland
Speaker 1: along with other folks that came by. Weeks later. I
Speaker 1: gave a nine even a presentation. I mean, if you
Speaker 1: think these slides are a bit elaboration in one hundred
Speaker 1: plus lights, I had for that. But after giving this
Speaker 1: presentation and went to all these different details about denvermers
Speaker 1: and different kinds of organic molecules and you know, different
Speaker 1: using plugy or open fundations and materfact delivery system all
Speaker 1: that kind of stuff. Are you like roaming around the house?
Speaker 1: Are you on your lag? Are you like crawling around
Speaker 1: like a marine? Or what's going on over there? Man,
Speaker 1: I'm sitting here in a shaer Oh it sound like
Speaker 1: you're going in and out of something. Oh no, I'm
Speaker 1: so sorry. Now you sound good, You sound good? Okay, well,
Speaker 1: I'm so sorry. I think I think probable breathing for
Speaker 1: them to be part of it. No breathing during the show,
Speaker 1: thank you very much. It up or no, no dying alone. Yeah,
Speaker 1: trying to have a show here, Okay, Yeah, the show
Speaker 1: go ahead and crop off. Okay, So anyway, getting back
Speaker 1: to the more realistic role, perhaps after ninety minutes or
Speaker 1: so of this presentation, a few of the folks, we're
Speaker 1: asking all these questions like, well, how do we regulate this?
Speaker 1: What do you suggest for regulatory protocol? How are we
Speaker 1: going to enforce any kind of new legal definitions for
Speaker 1: what these nanobiological systems should be? And I said, you know, frankly,
Speaker 1: it's not going to matter. The United States is no
Speaker 1: longer in a position to inflict its regulatory will upon
Speaker 1: the rest of the role as it might once have been.
Speaker 1: Very likely China is going to go ahead and do
Speaker 1: whatever they want to do, as I'm sure many other
Speaker 1: nations will as well. So rather than worry about regulatory
Speaker 1: protocols and the limitations thereof, look more towards sort of
Speaker 1: adapting to emotion, more global kind of way of assessing
Speaker 1: these properties. Listen to more Coast to Coast AM every
Speaker 1: weeknight at one am Eastern and go to Coast to
Speaker 1: Coast am dot com for more